Link between chronic pain and sleep
Chronic pain arising from structures such as the sacroiliac joint complex (SIJC) and cervical zygapophysial joints is frequently evaluated using multidimensional outcome frameworks that include pain intensity, function, mood, and sleep. In interventional pain studies, sleep is often captured as a secondary outcome alongside numeric pain rating scales and disability indices, reflecting the recognition that persistent nociception can interfere with restorative sleep and overall quality of life. For example, in a prospective study of radiofrequency (RF) ablation for cervicogenic headache and neck pain, secondary outcomes included mood, ambulation, sleep, and enjoyment of life, measured with a modified Brief Pain Inventory, underscoring the clinical relevance of sleep disturbance in chronic pain populations.
Low back pain, including pain attributed to the SIJC, affects a substantial proportion of adults and is described as having a multifactorial etiology. Within this context, pain is not viewed in isolation but as part of a broader symptom complex that can impair daily activities and nocturnal rest. Protocols for interventional trials in low back and sacroiliac pain therefore incorporate patient-reported outcomes that extend beyond pain intensity to capture domains such as function, health-related quality of life, and sleep-related impairment.
The inclusion of sleep-related measures in chronic pain research reflects the clinical observation that patients with persistent spinal or SIJ pain frequently report difficulty initiating or maintaining sleep, as well as non-restorative sleep. In the cervicogenic headache RF ablation cohort, sleep was explicitly tracked over multiple follow-up time points (1, 6, and 12 months), alongside pain and function, indicating that investigators anticipated meaningful interactions between pain relief and sleep outcomes.
In sacroiliac-focused RF protocols, pain-related sleep disturbance is treated as a distinct and measurable construct. The COBRA-SIJ protocol, which evaluates conventional versus bipolar RF ablation for SIJ pain, specifies improvement in pain-related sleep disturbance as a secondary outcome, measured with the Pain and Sleep Questionnaire (PSQ-3). By formally integrating a sleep-focused tool into the outcome set, the protocol operationalizes the link between chronic SIJ pain and sleep disturbance and allows investigators to quantify whether targeted nociceptive interventions translate into better sleep.
How RF may improve sleep quality
Radiofrequency neurotomy or ablation is designed to interrupt nociceptive signaling from innervated pain generators such as facet joints, the SIJC, and specific cervical targets. RF neurotomy is described as a standard interventional procedure for treating pain from innervated structures, with expanded use across spinal and peripheral joint targets. By reducing ongoing nociceptive input, RF interventions have the potential to alleviate symptoms that interfere with sleep, although sleep is typically evaluated as a secondary rather than primary endpoint.
In the context of cervicogenic headache and neck pain, a prospective RF ablation study evaluated not only pain reduction but also changes in sleep using a modified Brief Pain Inventory. The study followed patients for up to 12 months, with repeated assessments of pain, mood, ambulation, sleep, and enjoyment of life. This design reflects an expectation that successful RF ablation at the third occipital nerve and cervical medial branches may improve sleep by decreasing pain intensity and associated headache burden, thereby reducing nocturnal awakenings and discomfort.
For SIJ-mediated low back pain, RF ablation of the posterior sacral network (PSN) is intended to interrupt pain signals originating from the SIJC. The COBRA-SIJ protocol notes that pain signals from the SIJC can be interrupted with image-guided percutaneous RF ablation of the PSN, with prior systematic review data suggesting that a substantial proportion of patients achieve at least 50% pain relief for six months after PSN ablation. By decreasing SIJ nociception, such interventions may reduce pain-related sleep disturbance, a hypothesis that is explicitly tested in the COBRA-SIJ study using the PSQ-3.
The COBRA-SIJ protocol lists improvement in pain-related sleep disturbance as measured by the PSQ-3 as a key secondary outcome, alongside pain intensity, disability, and health-related quality of life. This indicates that investigators anticipate that effective RF ablation, whether conventional or bipolar, could translate into better sleep outcomes. The protocol’s longitudinal design, with follow-up assessments at multiple time points up to 24 months, allows for evaluation of whether any RF-related improvements in pain are accompanied by sustained changes in sleep disturbance, thereby linking nociceptive modulation to potential improvements in sleep quality.
PSQ-3 tool: assessing pain-related sleep disturbance
The Pain and Sleep Questionnaire (PSQ-3) is incorporated into the COBRA-SIJ protocol as the primary instrument for quantifying pain-related sleep disturbance. Within this study, the PSQ-3 is used both at baseline and during follow-up to capture changes in sleep that are specifically attributed to pain. Baseline PSQ-3 scores are collected at the initial visit, alongside demographic data, pain intensity ratings, disability indices, and health-related quality of life measures, ensuring that sleep disturbance is characterized before any RF intervention is performed.
The protocol identifies improvement in pain-related sleep disturbance as measured by the PSQ-3 as a secondary outcome, positioning the PSQ-3 as a key tool for evaluating whether RF ablation of the PSN has a measurable impact on sleep. By specifying this outcome a priori, the study design allows for hypothesis-driven analysis of sleep changes, rather than treating sleep as an incidental or exploratory variable. This structured approach supports a more rigorous assessment of the relationship between targeted nociceptive interventions and sleep disturbance.
In addition to its role as an outcome measure, the PSQ-3 contributes to the overall clinical characterization of participants with SIJ pain. Baseline PSQ-3 scores, collected together with numeric pain ratings, Oswestry Disability Index (ODI) scores, EuroQol-5D (EQ-5D) scores, and opioid use, provide a multidimensional profile of each participant’s pain experience, functional status, and sleep-related impairment. This allows investigators to explore associations between initial sleep disturbance and other clinical variables, as well as to examine whether baseline sleep status influences response to RF ablation.
The use of the PSQ-3 in the COBRA-SIJ study complements other patient-reported outcome tools used in RF research. For example, in the cervicogenic headache RF ablation study, sleep was assessed as part of a modified Brief Pain Inventory, whereas in COBRA-SIJ, sleep disturbance is captured with a dedicated pain-and-sleep instrument. Together, these approaches illustrate a trend toward more systematic and instrument-based assessment of sleep in interventional pain trials, with the PSQ-3 serving as a focused measure of pain-related sleep disturbance in the SIJ RF context.
Evidence from the COBRA-SIJ study
The COBRA-SIJ study is a double-blind, randomized, comparative trial designed to evaluate conventional versus bipolar RF ablation for the treatment of SIJ pain. The protocol describes the SIJC as a diarthrodial, synovial joint with both anterior and posterior innervation, and identifies the PSN, comprising lateral branches of S1–S3 posterior rami with contributions from S4 and L5 dorsal ramus, as the primary target for RF ablation. Pain signals from the SIJC are interrupted via image-guided percutaneous RF ablation of this network, with the goal of reducing pain and disability in carefully selected patients.
Prior systematic review data cited in the protocol indicate that 32–89% of patients may achieve at least 50% pain relief for six months following PSN ablation, and 11–44% may achieve complete pain relief over the same period. These findings provide the rationale for further comparative evaluation of RF techniques, including conventional monopolar and bipolar strip lesion approaches. The COBRA-SIJ study is positioned to address heterogeneity in prior RF methods by directly comparing two RF strategies within a controlled, randomized framework.
Within this trial, sleep-related outcomes are integrated alongside traditional pain and function measures. The specific aims include determining the effect of PSN ablation on reducing pain-related sleep disturbance as measured by the PSQ-3, in addition to evaluating pain intensity (numeric rating scale), disability (ODI), health-related quality of life (EQ-5D), and patient global impression of change (PGIC). By embedding PSQ-3-based sleep assessment into the core outcome set, the COBRA-SIJ protocol ensures that any differences between conventional and bipolar RF ablation will be evaluated not only in terms of analgesia and function but also in terms of sleep disturbance.
The protocol emphasizes the potential significance of these findings, noting that the study will help fill a gap in knowledge regarding the impact of complete PSN ablation on clinical outcomes in SIJC pain. The results may influence the treatment paradigm for PSN neurotomy and encourage a more standardized approach to RF technologies. Because pain-related sleep disturbance is a prespecified outcome, any observed differences in PSQ-3 scores between treatment arms will contribute directly to understanding how RF technique selection may influence sleep in patients with chronic SIJ pain.
Longitudinal sleep outcomes
Longitudinal assessment is central to understanding how RF interventions affect sleep over time. In the COBRA-SIJ protocol, outcomes are assessed at multiple follow-up points, 3, 6, 12, 18, and 24 months, allowing investigators to track the trajectory of pain-related sleep disturbance as measured by the PSQ-3. This repeated-measures design enables evaluation of both early and sustained changes in sleep disturbance following PSN ablation, and facilitates comparison of temporal patterns between conventional and bipolar RF techniques.
Baseline PSQ-3 scores are obtained at the initial visit, prior to any RF intervention, establishing a reference point for subsequent comparisons. Alongside PSQ-3, baseline data include pain intensity, disability, EQ-5D, opioid use, and depressive symptoms (PHQ-9). This comprehensive baseline characterization supports longitudinal analyses that can relate changes in sleep disturbance to changes in pain, function, and mood over the 24-month follow-up period.
The importance of longitudinal follow-up for sleep outcomes is also reflected in other RF studies. In the cervicogenic headache RF ablation cohort, sleep was assessed at 1, 6, and 12 months, together with pain and function, to capture the durability of treatment effects. The investigators highlighted the absence of prior long-term prospective studies and designed their trial to evaluate multiple variables, including sleep, over a 12-month period. This approach parallels the COBRA-SIJ design, which extends follow-up to 24 months and incorporates a dedicated sleep instrument, PSQ-3.
By integrating repeated PSQ-3 assessments into a randomized RF trial, the COBRA-SIJ study is structured to generate longitudinal data on pain-related sleep disturbance in SIJ pain. These data will clarify whether improvements in sleep, if observed, are transient or sustained, and whether they differ between conventional and bipolar RF ablation. Such longitudinal information is essential for clinicians who must counsel patients with chronic SIJ pain about expected trajectories of both pain and sleep following RF-based interventions.
Integrating sleep data in treatment plans
The structured use of tools such as the PSQ-3 in the COBRA-SIJ protocol illustrates how sleep data can be integrated into interventional pain treatment planning. By collecting baseline PSQ-3 scores and tracking changes over time, clinicians and investigators can quantify the extent of pain-related sleep disturbance and evaluate whether RF ablation of the PSN modifies this domain. Incorporating sleep metrics alongside pain intensity, disability, and quality of life allows for a more comprehensive assessment of treatment impact in patients with SIJ pain.
In the cervicogenic headache RF ablation study, sleep was one of several secondary outcomes assessed with a modified Brief Pain Inventory, together with mood, ambulation, and enjoyment of life. This multidimensional outcome framework demonstrates that RF-based interventions are increasingly evaluated not only for analgesic efficacy but also for their influence on broader aspects of patient well-being, including sleep. Integrating such data into clinical decision-making can help clinicians understand how RF ablation may affect daily functioning and nocturnal rest in patients with chronic cervical pain.
For SIJ pain, the COBRA-SIJ protocol’s emphasis on PSQ-3 outcomes suggests that future treatment planning may consider both pain and sleep responses when evaluating RF options. The study aims include determining the effect of PSN ablation on reducing pain-related sleep disturbance and comparing outcomes between conventional and bipolar RF techniques. As such data become available, they may inform discussions about which RF approach is most appropriate for patients whose clinical presentation includes prominent sleep disturbance related to SIJ pain.
More broadly, the explicit measurement of sleep disturbance in RF trials underscores the importance of recognizing sleep as a clinically meaningful outcome in chronic pain management. Instruments such as the PSQ-3 provide a standardized method for capturing pain-related sleep impairment, enabling clinicians and researchers to track changes over time and to relate these changes to specific interventional strategies. As protocols like COBRA-SIJ generate outcome data, integrating sleep metrics into treatment plans may support more individualized and outcome-informed use of RF ablation in chronic spinal and SIJ pain.
Sources (Bibliography)
- Lee DW, Sayed D, Deer TR, et al. Latest Evidence-Based Application for Radiofrequency Neurotomy. Journal of Pain Research, 2021.
- Wright R, Allan K, Kraft M, Holley B. Radiofrequency Ablation Using a Novel Multitined Expandable Electrode: Device Description and Research Study. Minimally Invasive Surgery for Pain, 2012.
- Conger A. Conventional or Bipolar Radiofrequency Ablation for the Treatment of Sacroiliac Joint Pain? The COBRA-SIJ study, a Double-blind, Randomized, Comparative Trial, Protocol Version 3.0, 2023.